BackHanda Pharmaceuticals Overview

Handa Pharmaceuticals Accounts Payable

Handa Pharmaceuticals's accounts payable is $46M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$45.53M
↑ 160.60% YoYΔ $28.06M vs prior year quarter

Peer trimmed avg / median

Loading

Handa Pharmaceuticals Accounts Payable History

Loading

Handa Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

Handa Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Handa Pharmaceuticals (6620.TWO) FAQ

As of the most recent data (June 2026), 6620.TWO shows a accounts payable of $46M. That compares with $17M in the prior-year period — up 160.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6620.TWO's accounts payable is now $46M (was $17M) — a 160.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Handa Pharmaceuticals is outperforming or lagging.

Tracking 6620.TWO's accounts payable over time shows whether Handa Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $46M That compares with $17M in the prior-year period — up 160.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Handa Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $46M) with ownership activity and broader fundamentals.